ANDA 75961, held by Watson Labs Florida. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 75961 (Metformin Hydrochloride), held by Watson Labs Florida, was first approved by FDA on Jan 25, 2002, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 25, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 33Labeling · Standard review | Approved | None posted |
| Jul 14, 2026 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jul 14, 2026 | Supplement 32Labeling · Standard review | Approved | None posted |
| Oct 31, 2008 | Supplement 20Labeling | Approved | None posted |
| May 25, 2007 | Supplement 15Labeling | Approved | None posted |
| Dec 24, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Oct 8, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Jun 21, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Jun 21, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Apr 8, 2002 | Supplement 3Labeling | Approved | None posted |
| Jan 25, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters